Clinical Trials Directory

Trials / Completed

CompletedNCT02355314

Doppler-based Renal Resistive Index in Assessing Renal Dysfunction Reversibility in ICU Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
367 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute kidney injury (AKI) is common in intensive care unit (ICU) patients and remains associated with a dismal prognosis. The diagnosis of AKI relies on functional criteria (oliguria and serum creatinine elevation), which carry several important limitations. Additionally, the investigators lack biomarker that may predict short term renal prognosis. Doppler-based renal resistive index (RI) measurement is a rapid and noninvasive investigative tool that may hold promise for early AKI detection in ICU patients or in differentiating transient from persistent AKI in selected critically ill patients. Although several studies have suggested adequate performance in predicting short-term reversibility of AKI, most of these studies were performed in limited patient samples. Additionally, a recent study has identified discrepant results regarding its diagnostic performance. The main objective of this large prospective multicentre study is to assess diagnostic performance of Doppler-based renal resistive index in diagnosing persistent AKI in critically ill patients requiring mechanical ventilation.

Conditions

Interventions

TypeNameDescription
OTHERDoppler-based renalDoppler-based renal : day 0 and day 3
BIOLOGICALblood sample and urine sampleblood sample and urine sample : day 0 and day 3

Timeline

Start date
2013-12-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2015-02-04
Last updated
2016-09-20

Locations

5 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02355314. Inclusion in this directory is not an endorsement.